Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
do not take more than directed do not take more than 6 doses in 24 hours mL = milliliter only use the dose cup provided find right dose on chart below take every 4 to 6 hours, or as directed by a doctor Age (yr) Dose (mL) children under 2 years do not use children 2 to 5 years do not use unless directed by a doctor children 6 to 11 years 5 mL to 10 mL
each 5 mL contains: sodium 4 mg store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) see end flap for expiration date and lot number protect from light
Diphenhydramine HCl 12.5 mg
Antihistamine
taking sedatives or tranquilizers.
In case of overdose, get medical help or contact a Poison Control Center right away.
| Age (yr) | Dose (mL) |
| children under 2 years | do not use |
| children 2 to 5 years | do not use unless directed by a doctor |
| children 6 to 11 years | 5 mL to 10 mL |
anhydrous citric acid, D&C red #33, FD&C red #40, flavor, glycerin, high fructose corn syrup, purified water, sodium benzoate, sodium chloride, sodium citrate dihydrate, sucrose
1-800-426-9391
Family
Wellness™
*COMPARE TO THE
ACTIVE INGREDIENT
IN CHILDREN’S
BENADRYL® ALLERGY
children's
ALLERGY
RELIEF
AGES
6 TO 11
YEARS
Diphenhydramine HCl,
12.5 mg per 5 mL
Oral Solution
Antihistamine
Relieves:
• Sneezing
• Itchy, watery eyes
• Runny nose
• Itchy nose or throat
Alcohol-free
CHERRY
FLAVOR
4 FL OZ
(118 mL)
NDC 55319-315-36
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0032251933585 | GTIN-13: 0032251933585 EAN-13: 0032251933585 GTIN-12: 032251933585 UPC-A: 032251933585 GTIN storage (14 digits): 00032251933585 | family-wellness-44-015-1.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55319-315 | 55319-315-36 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | TC2D6JAD40 | ACTIB |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| D&C RED NO. 33 | 9DBA0SBB0L | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| HIGH FRUCTOSE CORN SYRUP | XY6UN3QB6S | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| TRISODIUM CITRATE DIHYDRATE | B22547B95K | IACT |
| SUCROSE | C151H8M554 | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 4 | 2025-09-02 | full-release | 2026-06-01 01:12:28 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f18be2ae-8aa9-4ecb-9ba5-1fc4f216c4cd | 44d9a74a-a27c-4ff2-b8b1-bf63811ecf54 | 2025-09-02 | Warnings | 44d9a74a-a27c-4ff2-b8b1-bf63811ecf54 |
Adverse event summaries are temporarily unavailable. Other product information remains available.